Bernstein initiated coverage of Procter & Gamble with a Market Perform rating and $156 price target. The company's challenges from private label in "more commoditized categories" like bathroom tissue and from smaller competitors in disposable diapers are unlikely to go away, the analyst tells investors in a research note. Bernstein's earnings growth estimates for Procter are below consensus.
